MAP1LC3B and malignant colon neoplasm: Colon cancer HCT116 and HCT116-NKD1 cells, or SW620 and SW620-nkd1−/− cells were treated with CHX and CQ, and LC3B antibodies were used to isolate the LC3B proteins from the cell lysates.